Phase I/Clinical Pharmacology Info Sheet
Overview
Providing crucial data in early clinical development is key to ensuring program success and product approval.
At Quotient Sciences, our comprehensive, end-to-end services encompass expert clinical study design, thorough data analysis, and detailed reporting. Bringing over three decades experience in clinical pharmacology to every customer program, our team has conducted over 2,000 Phase I studies in our US and UK clinical units, including more than 200 DDI studies and 400 human ADME studies.
Learn more about our capabilities in Phase I clinical pharmacology and regulatory & labeling studies today.